PortfoliosLab logo
ProShares UltraShort Nasdaq Biotechnology (BIS)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

ETF Info

ISIN

US74347B7890

CUSIP

74347G838

Issuer

ProShares

Inception Date

Apr 7, 2010

Region

North America (U.S.)

Leveraged

2x

Index Tracked

NASDAQ Biotechnology Index (-200%)

Asset Class

Equity

Asset Class Size

Multi-Cap

Asset Class Style

Growth

Expense Ratio

BIS has a high expense ratio of 0.95%, indicating above-average management fees.


Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart


Loading data...

Returns By Period

ProShares UltraShort Nasdaq Biotechnology (BIS) returned 10.74% year-to-date (YTD) and 15.86% over the past 12 months. Over the past 10 years, BIS returned -16.10% annually, underperforming the S&P 500 benchmark at 10.77%.


BIS

YTD

10.74%

1M

-6.50%

6M

33.69%

1Y

15.86%

5Y*

-10.59%

10Y*

-16.10%

^GSPC (Benchmark)

YTD

0.08%

1M

9.75%

6M

-1.63%

1Y

12.74%

5Y*

15.66%

10Y*

10.77%

*Annualized

Monthly Returns

The table below presents the monthly returns of BIS, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-8.96%0.36%13.02%-3.81%11.49%10.74%
2024-0.45%-1.80%0.40%13.54%-10.12%-6.26%-11.77%-1.43%4.92%6.11%-0.81%16.22%4.79%
2023-6.87%13.75%-2.47%-2.81%5.73%0.06%-2.07%1.32%8.97%14.73%-9.45%-21.67%-6.54%
202225.57%7.14%-10.70%20.24%-1.72%-5.41%-8.68%0.16%2.52%-17.13%-11.41%5.88%-2.14%
2021-12.50%3.75%5.47%-6.60%2.84%-15.06%-0.60%-9.57%9.13%3.33%7.24%0.40%-14.74%
202012.01%-2.33%-3.66%-27.80%-16.70%-5.19%1.62%-2.94%-2.35%5.67%-20.59%-9.43%-56.01%
2019-23.59%-5.78%0.76%9.71%12.18%-16.59%5.99%4.49%6.55%-14.24%-20.15%-1.95%-41.01%
2018-13.42%9.48%1.15%4.64%-9.27%-2.99%-11.76%-9.20%0.30%33.27%-10.13%23.71%5.14%
2017-10.20%-12.73%1.42%-3.06%7.49%-16.29%-6.02%-9.47%-0.29%12.20%-1.39%-3.16%-36.98%
201653.67%7.16%-7.87%-7.92%-10.12%15.42%-22.35%5.01%-6.81%24.89%-16.03%5.52%21.87%
2015-12.24%-9.86%-5.19%4.09%-17.21%-3.40%-8.50%20.78%21.46%-16.42%-6.70%-4.49%-37.59%
2014-16.38%-15.18%21.72%1.63%-9.28%-13.33%2.88%-18.29%0.58%-16.94%-5.76%-2.38%-55.43%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of BIS is 36, indicating average performance compared to other ETFs on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of BIS is 3636
Overall Rank
The Sharpe Ratio Rank of BIS is 3535
Sharpe Ratio Rank
The Sortino Ratio Rank of BIS is 4646
Sortino Ratio Rank
The Omega Ratio Rank of BIS is 3939
Omega Ratio Rank
The Calmar Ratio Rank of BIS is 2424
Calmar Ratio Rank
The Martin Ratio Rank of BIS is 3434
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for ProShares UltraShort Nasdaq Biotechnology (BIS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

ProShares UltraShort Nasdaq Biotechnology Sharpe ratios as of May 14, 2025 (values are recalculated daily):

  • 1-Year: 0.36
  • 5-Year: -0.23
  • 10-Year: -0.33
  • All Time: -0.64

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of ProShares UltraShort Nasdaq Biotechnology compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time. For deeper analysis or to customize the calculation, use the Sharpe ratio tool.


Loading data...

Dividends

Dividend History

ProShares UltraShort Nasdaq Biotechnology provided a 3.26% dividend yield over the last twelve months, with an annual payout of $0.65 per share.


0.00%1.00%2.00%3.00%4.00%$0.00$0.20$0.40$0.60$0.80$1.00$1.202018201920202021202220232024
Dividends
Dividend Yield
PeriodTTM2024202320222021202020192018
Dividend$0.65$0.68$0.32$0.00$0.00$0.10$1.13$0.34

Dividend yield

3.26%3.73%1.75%0.00%0.00%0.44%2.10%0.37%

Monthly Dividends

The table displays the monthly dividend distributions for ProShares UltraShort Nasdaq Biotechnology. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025$0.00$0.00$0.13$0.00$0.00$0.13
2024$0.00$0.00$0.16$0.00$0.00$0.16$0.00$0.00$0.15$0.00$0.00$0.21$0.68
2023$0.00$0.00$0.00$0.00$0.00$0.02$0.00$0.00$0.12$0.00$0.00$0.18$0.32
2022$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2021$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2020$0.00$0.00$0.10$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.10
2019$0.00$0.00$0.26$0.00$0.00$0.38$0.00$0.00$0.32$0.00$0.00$0.16$1.13
2018$0.07$0.00$0.00$0.27$0.34

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the ProShares UltraShort Nasdaq Biotechnology. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the ProShares UltraShort Nasdaq Biotechnology was 99.77%, occurring on Sep 19, 2024. The portfolio has not yet recovered.

The current ProShares UltraShort Nasdaq Biotechnology drawdown is 99.67%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.77%Jul 7, 20103482Sep 19, 2024
-13.04%Jun 10, 20103Jun 15, 20109Jul 1, 201012
-11.83%May 7, 20104May 12, 20105May 20, 20109
-9.45%May 27, 20104Jun 3, 20102Jun 8, 20106
-6.59%Apr 28, 20102Apr 29, 20104May 5, 20106

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...